Getein Biotech, Inc (SHA:603387)

Getein Biotech Revenue

Getein Biotech had revenue of 245.00M CNY in the quarter ending September 30, 2025, a decrease of -6.55%. This brings the company's revenue in the last twelve months to 1.04B, down -16.45% year-over-year. In the year 2024, Getein Biotech had annual revenue of 1.16B, down -14.93%.

• Revenue (ttm): 1.04B
• Revenue Growth: -16.45%
• P/S Ratio: 4.45
• Revenue / Employee: 535.52K
• Employees: 1,947
• Market Cap: 4.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.16B	-204.36M	-14.93%
Dec 31, 2023	1.37B	-452.70M	-24.85%
Dec 31, 2022	1.82B	420.16M	29.97%
Dec 31, 2021	1.40B	278.37M	24.78%
Dec 31, 2020	1.12B	155.13M	16.02%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 30, 2026

Data Sources Report a data error